- Home
- WFG vs TECH Comparison
WFG vs TECH Comparison
Compare WFG & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFG
- TECH
- Stock Information
- Founded
- WFG 1955
- TECH 1976
- Country
- WFG Canada
- TECH United States
- Employees
- WFG N/A
- TECH N/A
- Industry
- WFG
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WFG
- TECH Health Care
- Exchange
- WFG Nasdaq
- TECH Nasdaq
- Market Cap
- WFG 7.5B
- TECH 7.8B
- IPO Year
- WFG N/A
- TECH 1989
- Fundamental
- Price
- WFG $75.10
- TECH $49.15
- Analyst Decision
- WFG Buy
- TECH Buy
- Analyst Count
- WFG 3
- TECH 10
- Target Price
- WFG $105.00
- TECH $73.44
- AVG Volume (30 Days)
- WFG 166.7K
- TECH 2.3M
- Earning Date
- WFG 04-22-2025
- TECH 05-07-2025
- Dividend Yield
- WFG 1.70%
- TECH 0.65%
- EPS Growth
- WFG N/A
- TECH N/A
- EPS
- WFG N/A
- TECH 0.83
- Revenue
- WFG $6,006,000,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- WFG $1.36
- TECH $8.19
- Revenue Next Year
- WFG $8.10
- TECH $8.61
- P/E Ratio
- WFG N/A
- TECH $59.07
- Revenue Growth
- WFG N/A
- TECH 4.72
- 52 Week Low
- WFG $69.48
- TECH $46.44
- 52 Week High
- WFG $102.40
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- WFG 51.47
- TECH 44.74
- Support Level
- WFG $73.22
- TECH $46.35
- Resistance Level
- WFG $77.38
- TECH $54.40
- Average True Range (ATR)
- WFG 1.57
- TECH 2.17
- MACD
- WFG 0.20
- TECH 0.27
- Stochastic Oscillator
- WFG 60.89
- TECH 34.78
About WFG West Fraser Timber Co. Ltd Common stock
West Fraser Timber is a softwood lumber company that also produces wood panels and pulp products. The company produces its wood products globally, with lumber mills in British Columbia, Alberta, Europe, and the southeastern United States. Following its acquisition of Norbord in 2021, West Fraser is now one of the largest oriented strand board, or OSB, producers in the world.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.